UPDATED Apr 29, 2024
Stocks with a market cap under US$50M.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WAFR | UK£0.25 | 0% | -30.6% | UK£938.8k | n/a | PB0.3x | n/a | n/a | Real Estate | ||
MNRG | UK£0.00075 | 3.4% | 0% | UK£923.8k | n/a | PE-0.5x | n/a | n/a | Materials | ||
PTY | UK£0.0088 | 0% | -81.6% | UK£901.9k | n/a | PB0.3x | n/a | n/a | Commercial Services | ||
OBSNZ | CHF0.018 | 0% | -78.4% | CHF1.0m | n/a | PE0.1x | n/a | n/a | Pharmaceuticals & Biotech | ||
UKR | UK£0.022 | -26.7% | -2.2% | UK£888.7k | n/a | PE19x | n/a | n/a | Food, Beverage & Tobacco | ||
BIEM | €0.035 | 0% | n/a | €932.6k | n/a | PS1.5x | n/a | 0% | Household | ||
PTD | UK£0.054 | 0% | -90.1% | UK£772.6k | n/a | PE1.9x | S3.8% | 18.6% | Consumer Durables | ||
0I5R | US$1.00 | 0% | n/a | US$925.8k | n/a | PE5.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
INSP | UK£0.00009 | 12.5% | -71.9% | UK£597.3k | n/a | PB0.2x | n/a | n/a | Capital Goods | ||
UVEL | UK£0.0015 | 0% | n/a | UK£575.5k | n/a | PE-0.05x | n/a | 0% | Tech | ||
SCGL | UK£0.00075 | 0% | -48.3% | UK£543.7k | n/a | PS2.6x | n/a | n/a | Media | ||
PTR | €0.00085 | 0% | -89.4% | €535.9k | n/a | PB0.01x | n/a | n/a | Energy | ||
SFE | UK£0.0032 | 0% | -98.8% | UK£444.4k | n/a | PB0.02x | E110.2% | 0% | Capital Goods | ||
GDH | UK£0.0047 | 0% | -53.7% | UK£416.2k | n/a | PB0.3x | n/a | n/a | Diversified Financials | ||
0R8A | €0.088 | 0% | n/a | €204.0k | n/a | PE-0.01x | E20.1% | n/a | Tech | ||
NSFL | UK£0.0018 | 0% | -91.0% | UK£125.0k | n/a | PE-0.002x | E104.0% | 0% | Diversified Financials | ||
0Y5F | US$0.0006 | 0% | -99.0% | US$141.1k | n/a | PE-0.00006x | n/a | n/a | Pharmaceuticals & Biotech |